BB Biotech AG
Company Information

Schwertstrasse 6
Schaffhausen, Schaffhausen, 8200 Switzerland

Top 3 Competitors

Unlock more access to Hoover’s!

  • Build customized email lists 24/7, based on your best customer profile.
  • Learn more about the companies you want to sell to. Hoover’s has reports on 85+ million companies and 900 industries. 65,000 data points are updated each day.
  • Get real insight written by real people – exclusive research and reviews by our in-house Editorial staff.
  • We can deliver our data to your desktop, to Excel, direct to your CRM, into your custom app, or via mobile.

Call (866) 473-3932 today to get started with a FREE TRIAL!


BB Biotech AG Company Profile

BB BIOTECH banks on genetics. The investment firm funds private and public biotechnology companies worldwide. BB BIOTECH's portfolio includes significant stakes in about five companies including Actelion, Isis Pharmaceuticals, and Celgene. The company rounds out its portfolio with smaller stakes in another five firms, keeping its holdings below 5%. BB BIOTECH prefers to invest in well-managed small- to mid-sized companies that are within two years of bringing a product to market. It focuses on listed companies. The company has some CHF 2 billion (nearly $2.1 billion) under management. Founded in 1993, BB BIOTECH was an early investor in Amgen, one of the world's biggest biotechnology companies.